Skip to content

Comparison of FAUCS vs. Misgav Ladach

Comparison Between French Ambulatory Cesarean Section to The Misgav-Ladach Technique - Double Blind Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03812406
Enrollment
120
Registered
2019-01-23
Start date
2018-08-19
Completion date
2019-09-19
Last updated
2019-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ambulation Difficulty, Pain, Postoperative

Keywords

cesarean

Brief summary

This study aims to compare two techniques for performing a cesarean delivery: Misgav Ladach versus French Ambulatory Cesarean Section (FAUCS). The second techniques has been claimed to reduce post-operative pain, the need for analgesics, and reduce the time for ambulation. Such comparison has not been done so far, and this study will examined if indeed the FAUCS techniques offers any advantages.

Detailed description

The FAUCS technique for performing a cesarean section has been described by a French group several years ago, and is claimed to reduce postoperative pain and increase ambulation. With this technique, after making the transverse skin incision, the fascia is opened vertically and to the left of the linea alba. The left rectus abdominis muscle is then pushed laterally, and the abdominal cavity is entered. The uterine incision in performed as usual. Due to the reduced incision size, a special spatula is used to facilitate extraction of the fetal head in some cases. No urinary catheter is used during or after the operation, and fluid administration is restricted during the procedure. The patient is encouraged to get out of bed 3-4 hours post surgery. This technique for performing a cesarean section will be compared with the traditional (Misgav Ladach technique) in terms of post-operative pain, need for analgesics, ambulation, neonatal outcome, and perioperative complications.

Interventions

PROCEDUREFrench Abulatory Cesrean Section

A cesarean section performed according to the FAUCS technique

PROCEDUREMisgav-Ladach

A cesarean section performed according to the Misgav Ladach technique

Sponsors

Bnai Zion Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patients scheduled for a cesarean section * term pregnancy: 37-42 weeks * singleton pregnancy * age 18 and above * patients capable of signing an informed consent

Exclusion criteria

* multiple pregnancy * emergency cesarean * previous 3 cesareans and above * placenta accreta * uterine myomas in the lower segment * fetal growth restriction * fetal anemia * preeclampsia * women scheduled for general anesthesia

Design outcomes

Primary

MeasureTime frameDescription
Composite maternal adverse outcome24 hours post surgeryThe rate of women with a composite maternal adverse outcome, defined as at least one of the following: Visual Analogue Scale score \>6 (scale of 1-10, 1 being a very mild pain, 10 being the worst pain imagineable) at 3-4 hours post surgery, inability to ambulate 3-4 hours post surgery, and QoR15 (Quality of Recovery) score \< 90 (range 0 to 150, 150 being the best recovery after surgery) at 24 hours post surgery

Secondary

MeasureTime frameDescription
Length of surgery24 hoursThe duration of surgery (in minutes) from incision until closure.
Blood loss (ml) during surgery24 hoursThe estimated volume of blood (in ml) lost during surgery
Birthweightimmediately after birthThe weight (grams) of the neonate immediately after birth
Cord pHimmediately after birthThe pH measured in a blood sample from the umbilical artery
Birth trauma24 hoursThe rate of birthtrauma in diagnosed in the neonate (shoulder dystocia, fracture, cerebral hemorrhage, cephalhematoma, etc.)

Countries

Israel

Contacts

Primary ContactRami Sammour, MD
rsammour2002@gmail.com+972506267390

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026